{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Wilsonville",
      "state": "OR",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "69519",
      "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds",
      "address_1": "8560 Sw Salish Ln Ste 100",
      "address_2": "N/A",
      "postal_code": "97070-9625",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Oregon, Washington",
      "recall_number": "D-0175-2015",
      "product_description": "ASCORBIC ACID (B), 500 mg/mL, injectable, 100 mL glass vial,  RX, Creative Compounds, Wilsonville, OR 97070.",
      "product_quantity": "2500 mL",
      "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.",
      "recall_initiation_date": "20141006",
      "center_classification_date": "20141031",
      "termination_date": "20150630",
      "report_date": "20141112",
      "code_info": "Lot #: 20140821@17, discard date:10/20/2014"
    }
  ]
}